Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Matson Inc (MATX) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Matson IncTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Matson Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Matson Inc trades at $237.82 (market cap $7.03B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Matson Inc is far larger — about 3.9× Vir Biotechnology Inc. Common Stock's market cap, and Matson Inc pays a 0.65% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Matson Inc for 25 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

MATXVIR
Market Cap
$7.03B$1.80B
Volume
327,6301,782,836
Sector
IndustrialsHealth
52-Week High
$238.60$11.78
52-Week Low
$93.22$5.12
Typical Hold Time
25 Days0 Days
Enterprise Value
$7.63B$1.36B
Dividend Yield
0.65%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Matson Inc

Matson (MATX) trades at $235.22, up 3.31% with strong bullish momentum supported by consistent earnings beats and positive technical indicators. The stock shows robust fundamentals with a 13.41% net income margin and 17.21% ROE, while valuation metrics remain reasonable with a P/E of 15.87. Recent Q2 2026 results exceeded expectations with EPS of $4.27 versus $3.79 expected, driving positive sentiment.

Outlook remains positive with Wall Street analysts projecting 27.3% upside potential and strong institutional buying activity. Key risks include freight market volatility and competitive pressures, but the company's raised full-year guidance and dividend payments provide stability for investors seeking transportation sector exposure.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MATX

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Matson Inc

Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.

Read more on MATX →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →